Relevant bibliographies by topics / Respiratory Diseases / Journal articles

Journal articles on the topic 'Respiratory Diseases'

To see the other types of publications on this topic, follow the link: Respiratory Diseases.
Author: Grafiati
Published: 4 June 2021
Last updated: 1 June 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Respiratory Diseases.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Gianoutsos, Peter. "Respiratory diseases." Medical Journal of Australia 152, no. 2 (January 1990): 102–3. http://dx.doi.org/10.5694/j.1326-5377.1990.tb124474.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

James, D. G., and O. M. Sharma. "Respiratory diseases." Postgraduate Medical Journal 66, no. 771 (January 1, 1990): 1–15. http://dx.doi.org/10.1136/pgmj.66.771.1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

James, D. G. "Respiratory diseases." Postgraduate Medical Journal 68, no. 797 (March 1, 1992): 160–73. http://dx.doi.org/10.1136/pgmj.68.797.160.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Frossard, Nelly. "Respiratory diseases." Drug Discovery Today: Disease Models 3, no. 3 (September 2006): 197–98. http://dx.doi.org/10.1016/j.ddmod.2006.10.003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Suwabe, Akira. "1. Respiratory Diseases." Nihon Naika Gakkai Zasshi 97, no. 12 (2008): 2927–35. http://dx.doi.org/10.2169/naika.97.2927.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Tojo, Naoko. "2. Respiratory Diseases." Nihon Naika Gakkai Zasshi 100, no. 11 (2011): 3209–14. http://dx.doi.org/10.2169/naika.100.3209.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Ramsdale, Helen. "New Respiratory Diseases." Canadian Respiratory Journal 10, no. 3 (2003): 131–32. http://dx.doi.org/10.1155/2003/854839.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Beckett, William S. "Occupational Respiratory Diseases." New England Journal of Medicine 342, no. 6 (February 10, 2000): 406–13. http://dx.doi.org/10.1056/nejm200002103420607.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Kilgore, David, and Wadie Najm. "Common Respiratory Diseases." Primary Care: Clinics in Office Practice 37, no. 2 (June 2010): 297–324. http://dx.doi.org/10.1016/j.pop.2010.02.007.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Merchant, James. "Agricultural Respiratory Diseases." Seminars in Respiratory and Critical Care Medicine 7, no. 03 (January 1986): 211–24. http://dx.doi.org/10.1055/s-2007-1012617.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Balmes, John R. "OCCUPATIONAL RESPIRATORY DISEASES." Primary Care: Clinics in Office Practice 27, no. 4 (December 2000): 1009–37. http://dx.doi.org/10.1016/s0095-4543(05)70187-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

Moise, N. Sydney. "Viral Respiratory Diseases." Veterinary Clinics of North America: Small Animal Practice 15, no. 5 (September 1985): 919–28. http://dx.doi.org/10.1016/s0195-5616(85)50102-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

Hoskins, Johnny D. "Feline Respiratory Diseases." Veterinary Clinics of North America: Small Animal Practice 29, no. 4 (July 1999): 945–58. http://dx.doi.org/10.1016/s0195-5616(99)50083-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Kendrick, Roger E. "Ferret Respiratory Diseases." Veterinary Clinics of North America: Exotic Animal Practice 3, no. 2 (May 2000): 453–64. http://dx.doi.org/10.1016/s1094-9194(17)30081-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

Nichols, Donald K. "Amphibian Respiratory Diseases." Veterinary Clinics of North America: Exotic Animal Practice 3, no. 2 (May 2000): 551–54. http://dx.doi.org/10.1016/s1094-9194(17)30089-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Holland, W. W. "Chronic respiratory diseases." Journal of Epidemiology & Community Health 47, no. 1 (February 1, 1993): 4–5. http://dx.doi.org/10.1136/jech.47.1.4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Maio, S., S. Baldacci, M. Borbotti, A. Angino, F. Martini, B. Piegaia, P. Silvi, M. Simoni, F. Di Pede, and G. Viegi. "Respiratory allergic diseases." World Allergy Organization Journal &NA; (November 2007): S180. http://dx.doi.org/10.1097/01.wox.0000301833.17048.6f.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

Geltser, B. I., I. G. Kurpatov, A. A. Dej, and A. G. Kozhanov. "Respiratory muscles dysfunction and respiratory diseases." Terapevticheskii arkhiv 91, no. 3 (March 15, 2019): 93–100. http://dx.doi.org/10.26442/00403660.2019.03.000108.

Full text
Abstract:
This review presents an analysis of the literature on the topic of respiratory muscle (RM) dysfunction in various forms of respiratory pathology: chronic obstructive pulmonary disease (COPD), asthma, community-acquired pneumonia, idiopathic pulmonary fibrosis (IPF), sarcoidosis and interstitial lung diseases (ILD), associated with systemic connective tissue diseases (polymyositis, dermatomyositis and systemic lupus erythematosus - SLE). Various clinical and pathophysiological aspects of RM dysfunction and general patterns of its pathogenesis were examined. It was proved that the role of RM in the development of respiratory failure depends on the form and stage of the pulmonary pathology and the severity of systemic manifestations of these diseases: excessive proteolysis, oxidative stress, hypoxia, chronic systemic inflammation. These factors modify the morphofunctional status of RM, worsens their contractile function, which is contributed to the development of respiratory failure. In some cases, the primary weakness of RM precedes the clinical manifestation of pulmonary pathology, which is distinctive for some variants of myositis-associated ILD and SLE. Endogenous intoxication syndrome plays a significant role in the development of RM dysfunction during community-acquired pneumonia. It is noted that sarcoid pulmonary ventilation disorders associate with the RM weakness, but not with the degree of lung damage. In most cases, secondary RM dysfunction predominates that contributes to respiratory failure progression, which is especially noticeable in case of COPD, asthma and IPF.
APA, Harvard, Vancouver, ISO, and other styles
19

Tatsumi, Koichiro. "Respiratory diseases as lifestyle-related diseases." Health Evaluation and Promotion 39, no. 6 (2012): 821–28. http://dx.doi.org/10.7143/jhep.39.821.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Paramjyothi, G. "Respiratory Diseases and Coronary Artery Diseases." Indian Journal of Cardiovascular Disease in Women WINCARS 02, no. 01 (March 2017): 056–67. http://dx.doi.org/10.1055/s-0038-1656461.

Full text
APA, Harvard, Vancouver, ISO, and other styles
21

Cheberyachko, S., Yu Cheberyachko, D. Radchuk, O. Deryugin, D. Klimov, O. Sharovatova, and V. Gridiaiev. "INDIVIDUAL RESPIRATORY PROTECTION EQUIPMENT: INNOVATIONS TO REDUCE THE RISK OF OCCUPATIONAL DISEASES." Municipal economy of cities 1, no. 175 (April 3, 2023): 221–28. http://dx.doi.org/10.33042/2522-1809-2023-1-175-221-228.

Full text
Abstract:
Individual respiratory protective equipment (PPE) is the last barrier to protect workers when performing production tasks in harmful and dangerous working conditions. The article analyzes modern innovative designs of personal respiratory protective equipment, which increase the level of protection of users during their operation. The method of morphological analysis is applied. This method based on the selection of possible solutions for assessing the manufacturability of PPE models (if there is a system of criteria) and making a rational decision regarding the features of their application in production conditions. As a result, it was established that in order to ensure the appropriate duration of the protective action of gas and dust filters and to avoid both poisoning of workers due to the ingress of harmful aerosols into the sub-mask space of the filter respirator, and excessive physical exhaustion due to the increase in pressure drop above the standard substances, it is recommended to equip the filters with special indicators for determining air pollution and pressure drop values. It was determined that in order to increase the reliability of the protection of workers, it is necessary to equip filter respirators with the functions of operational control of breathing resistance, place a headrest to control the occurrence of possible gaps behind the obturation band when performing various production operations, and establish the real term of the protective effect of the filters. The practical value of the work is innovative solutions to improve the designs of existing filter respirators, which will allow control over technological parameters during operation. In particular, the density along the obturation strip and the magnitude of the tension force of the respirator headgear. Recommendations are also given for controlling the term of the protective action of gas filters, since determining the specified indicators based on the organoleptic abilities of the user is dangerous for health. Keywords: risk, means of individual protection of respiratory organs, filtering respirator.
APA, Harvard, Vancouver, ISO, and other styles
22

Cheberiachko, S. I., O. O. Yavorska, A. V. Yavorskyi, and M. Yu Ikonnikov. "A risk of pulmonary diseases in miners while using dust respirators." Naukovyi Visnyk Natsionalnoho Hirnychoho Universytetu, no. 5 (October 30, 2022): 104–9. http://dx.doi.org/10.33271/nvngu/2022-5/104.

Full text
Abstract:
Purpose. To determine magnitudes of the occupational risks of respiratory disease (pneumoconiosis) occurrence in miners while using filter respirators on the basis of an exposure dust dose with the consideration of work experience. Methodology. To assess occupational risks, a new approach proposed by the Research Institute of Complex Hygiene and Occupational Diseases is used. The approach is based on determining an exposure dose of a hazardous substance entering the workers lungs during their professional contact with it taking into account the volume of pulmonary ventilation, the number of shifts, and work experience. Findings. Use of dust respirators reduces the risk of occupational respiratory diseases but does not eliminate it completely. It has been established that with more than three-year work experience and coal dust concentrations of more than 50 mg/m3, use of dust filter respirators does not ensure a minimal degree of the occupational disease risks. At the same time, it has been identified that if work experience is less than 3 years with the use of filter respirators, the risk of occupational diseases will be minimal. It has been proved that the risk assessment should involve using the minimal value of a protection factor of a respirator, which is fixed in the production environment. It has been shown that working within the areas with dust concentrations higher than 100 mg/m3 is dangerous for miners; over time, with the accumulation of sufficient dust in the lungs it will lead to the development of silicosis. Originality. It consists in scientific substantiation of the magnitude of occupational risk of respiratory diseases in miners, taking into account a real protection factor of respirators, which is determined at the workplace based on the calculation of an exposure dose and time of professional contact with hazardous substances. Practical value. The experience of safe operation in mine workings with and without using filter respirators has been substantiated, basing on a safe value of coal dust concentration, at which a low level of occupational risk of respiratory diseases is recorded. Recommendations for determining the dust load taking into account a protection factor of respirators at the workplace have been developed.
APA, Harvard, Vancouver, ISO, and other styles
23

Arif, Shahrukh, and Margaret A. Pisani. "Aging and Respiratory Diseases." US Respiratory & Pulmonary Diseases 5, no. 1 (2020): 33. http://dx.doi.org/10.17925/usprd.2020.5.1.33.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Bakulin, I. G., O. Yu Chizhova, L. N. Belousova, E. Yu Pavlova, A. G. Sushilova, A. D. Sheiko, and M. K. Alieva. "Respiratory Diseases and Hyperammoniemia." Doctor.Ru 19, no. 11 (2020): 32–37. http://dx.doi.org/10.31550/1727-2378-2020-19-11-32-37.

Full text
Abstract:
Study Objective: To assess the incidence of hyperammoniemia in respiratory diseases. Materials and Methods. 36 patients with respiratory diseases took part in the study: chronic obstructive pulmonary disease (COPD) (21 (58.3%) patients), chronic bronchitis (5 (13.9%) patients), and pneumonia (10 (27.8%) patients). Mean age was 66.8 ± 11.8 years; 9 (25.0%) females and 27 (75.0%) males. Each patient had his/her capillary ammonia measured (microdiffusion). In order to assess the nutrition status, all patients had their primary somatometry measured: height, weight, body mass index, inactive arm circumference, waist circumference, skin-fat rolls thickness under biceps, above triceps, below shoulder blade angle, in inguinal region. Study Results. 9 (25.0%) out of 36 patients had hyperammoniemia (capillary ammonia level: 74.0 ± 7.1 nmol/L); their mean age was 62.3 ± 18.2 years. Patients with COPD/chronic bronchitis had significantly higher ammonia concentration (60.7 ± 16.6 mol/L) vs. patients with pneumonia (48.4 ± 14.3 mol/L; t = 2.2, p < 0.03). COPD patients demonstrated significant differences in ammonia levels depending on duration of disease. In the group of higher ammonia concentration, COPD lasted significantly longer (t = 4.03 p = 0.001). We did not find any sound correlation between nutritional (trophological) status and ammonia concentrations in patients with respiratory diseases (t < 2, p > 0.05). Conclusion. In 25% of cases, respiratory diseases were associated with hyperammoniemia that is non-cirrhotic, because hepatobiliary disorders in this group of patients were an exclusion criterion. Although no statistically significant correlation between non-cirrhotic hyperammoniemia and nutritional (trophological) status was demonstrated, pathogenic relations between them cannot be ruled out. Whether underweight is a determining factor in non-cirrhotic hyperammoniemia is still unclear and requires further research and more observations. Keywords: ammonia, non-cirrhotic hyperammoniemia, nutritional (trophological) status, respiratory diseases.
APA, Harvard, Vancouver, ISO, and other styles
25

Białek-Gosk, Katarzyna. "Guaifenesin in respiratory diseases." Medycyna Faktów 13, no. 1 (March 31, 2020): 82–86. http://dx.doi.org/10.24292/01.mf.0120.9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

Raghu, Srikanti, and SuryaKiran Pulivarthi. "Respiratory diseases in pregnancy." Journal of Clinical and Scientific Research 4, no. 2 (2015): 149. http://dx.doi.org/10.15380/2277-5706.jcsr.14.048.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Gałuszka, Aleksandra. "Physiotherapy for respiratory diseases." Journal of Education, Health and Sport 12, no. 8 (August 24, 2022): 1002–11. http://dx.doi.org/10.12775/jehs.2022.12.08.084.

Full text
Abstract:
The respiratory system is crucial to human life. Its performance determines the quality of life. Physical training helps patients suffering from various diseases of this system to build up physical fitness, improve breathing mechanics and reduce clumsy secretion in the bronchial tree. The right choice of techniques for working with such a patient is important. They use fitness training, strength training, breathing exercises, bronchial tree cleansing. Always consider possible contraindications
APA, Harvard, Vancouver, ISO, and other styles
28

Comolli, Jessica R., and Stephen J. Divers. "Respiratory Diseases of Snakes." Veterinary Clinics of North America: Exotic Animal Practice 24, no. 2 (May 2021): 321–40. http://dx.doi.org/10.1016/j.cvex.2021.01.003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Mahajan, Vineet, and Jatinder Singh. "Prevention of Respiratory Diseases." International Journal of Medical and Dental Sciences 4, no. 1 (January 1, 2015): 721. http://dx.doi.org/10.19056/ijmdsjssmes/2015/v4i1/79968.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

INOUE, HIROSHI. "Respiratory diseases and NO." Nihon Naika Gakkai Zasshi 86, no. 9 (1997): 1795–99. http://dx.doi.org/10.2169/naika.86.1795.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

DiMauro, Salvatore, and Eric A. Schon. "Mitochondrial Respiratory-Chain Diseases." New England Journal of Medicine 348, no. 26 (June 26, 2003): 2656–68. http://dx.doi.org/10.1056/nejmra022567.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

Benato, Livia. "Respiratory diseases in rats." Companion Animal 17, no. 4 (May 2012): 47–50. http://dx.doi.org/10.1111/j.2044-3862.2012.00163.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Cockcroft, A. "Prevention of Respiratory Diseases." Occupational and Environmental Medicine 52, no. 6 (June 1, 1995): 432. http://dx.doi.org/10.1136/oem.52.6.432.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Kumar, RVijai. "Breathlessness & respiratory diseases." Lung India 23, no. 1 (2006): 34. http://dx.doi.org/10.4103/0970-2113.44428.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Rupani, Hitasha, Tilman Sanchez-Elsner, and Peter Howarth. "MicroRNAs and respiratory diseases." European Respiratory Journal 41, no. 3 (July 12, 2012): 695–705. http://dx.doi.org/10.1183/09031936.00212011.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

Murugan, AT, and G. Sharma. "Obesity and respiratory diseases." Chronic Respiratory Disease 5, no. 4 (November 2008): 233–42. http://dx.doi.org/10.1177/1479972308096978.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

Dagan, Ron, and Philippe Lepage. "Introduction: Childhood Respiratory Diseases." Pediatric Infectious Disease Journal 28 (October 2009): S119—S120. http://dx.doi.org/10.1097/inf.0b013e3181b6d7d5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

Nohynek, Hanna, Shabir Madhi, and Carlos G. Grijalva. "Childhood Bacterial Respiratory Diseases." Pediatric Infectious Disease Journal 28 (October 2009): S127—S132. http://dx.doi.org/10.1097/inf.0b013e3181b6d800.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Dobler, Claudia C. "Biomarkers in respiratory diseases." Breathe 15, no. 4 (December 2019): 265–66. http://dx.doi.org/10.1183/20734735.0329-2019.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Miller, Robert. "HIV-associated respiratory diseases." Lancet 348, no. 9023 (August 1996): 307–12. http://dx.doi.org/10.1016/s0140-6736(95)11037-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

Rabe, Klaus F. "Understanding chronic respiratory diseases." Lancet 372, no. 9643 (September 2008): 1027–28. http://dx.doi.org/10.1016/s0140-6736(08)61426-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Schumacher, Juergen. "Respiratory diseases of reptiles." Seminars in Avian and Exotic Pet Medicine 6, no. 4 (October 1997): 209–15. http://dx.doi.org/10.1016/s1055-937x(97)80007-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

Zandbergen, J., H. Pols, M. Bright, C. De Loof, and E. Griez. "Respiratory diseases in panic." Biological Psychology 31, no. 3 (December 1990): 283. http://dx.doi.org/10.1016/0301-0511(90)90057-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Pison, Ulrich, Tobias Welte, Michael Giersig, and David A. Groneberg. "Nanomedicine for respiratory diseases." European Journal of Pharmacology 533, no. 1-3 (March 2006): 341–50. http://dx.doi.org/10.1016/j.ejphar.2005.12.068.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

Witkowska, Anna, Marta Wiszniewska, and Jolanta Walusiak-Skorupa. "Rare occupational respiratory diseases." Medycyna Pracy 71, no. 1 (January 20, 2020): 89–104. http://dx.doi.org/10.13075/mp.5893.00895.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Deeb, Barbara J., and Ronald E. DiGiacomo. "Respiratory Diseases of Rabbits." Veterinary Clinics of North America: Exotic Animal Practice 3, no. 2 (May 2000): 465–80. http://dx.doi.org/10.1016/s1094-9194(17)30082-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

Schoeb, Trenton R. "Respiratory Diseases of Rodents." Veterinary Clinics of North America: Exotic Animal Practice 3, no. 2 (May 2000): 481–96. http://dx.doi.org/10.1016/s1094-9194(17)30083-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

de Benedictis, Fernando Maria, Roberto Guidi, Silvia Carraro, and Eugenio Baraldi. "Endpoints in respiratory diseases." European Journal of Clinical Pharmacology 67, S1 (November 23, 2010): 49–59. http://dx.doi.org/10.1007/s00228-010-0922-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

Ebihara, Satoru, Ikuko Okuni, Midori Miyagi, and Hideaki Izukura. "Rehabilitation for Respiratory Diseases." Japanese Journal of Rehabilitation Medicine 53, no. 11 (2016): 829–33. http://dx.doi.org/10.2490/jjrmc.53.829.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Prakash, Udaya B. S. "Respiratory Diseases in Rwanda." Chest 108, no. 1 (July 1995): 5–7. http://dx.doi.org/10.1378/chest.108.1.5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the bibliographies on the topic 'Respiratory Diseases' for other source types:
Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography